Free Trial
NYSE:PHR

Phreesia (PHR) Stock Price, News & Analysis

Phreesia logo
$9.82 +0.29 (+3.03%)
Closing price 03:59 PM Eastern
Extended Trading
$9.64 -0.18 (-1.82%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Phreesia Stock (NYSE:PHR)

Advanced

Key Stats

Today's Range
$9.56
$10.05
50-Day Range
$8.06
$12.62
52-Week Range
$7.77
$32.76
Volume
1.38 million shs
Average Volume
1.49 million shs
Market Capitalization
$596.60 million
P/E Ratio
59.56
Dividend Yield
N/A
Price Target
$20.82
Consensus Rating
Moderate Buy

Company Overview

Phreesia Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
82nd Percentile Overall Score

PHR MarketRank™: 

Phreesia scored higher than 82% of companies evaluated by MarketBeat, and ranked 103rd out of 860 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Phreesia has received a consensus rating of Moderate Buy. The company's average rating score is 2.58, and is based on no strong buy ratings, 12 buy ratings, 6 hold ratings, and 1 sell rating.

  • Upside Potential

    Phreesia has a consensus price target of $20.82, representing about 112.1% upside from its current price of $9.82.

  • Amount of Analyst Coverage

    Phreesia has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Phreesia's stock forecast and price target.
  • Earnings Growth

    Earnings for Phreesia are expected to grow by 89.29% in the coming year, from $0.28 to $0.53 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Phreesia is 327.30, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.44.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Phreesia is 327.30, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.56.

  • Price to Book Value per Share Ratio

    Phreesia has a P/B Ratio of 1.76. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Phreesia's valuation and earnings.
  • Percentage of Shares Shorted

    6.30% of the float of Phreesia has been sold short.
  • Short Interest Ratio / Days to Cover

    Phreesia has a short interest ratio ("days to cover") of 1.39, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Phreesia has recently decreased by 7.46%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Phreesia does not currently pay a dividend.

  • Dividend Growth

    Phreesia does not have a long track record of dividend growth.

  • News Sentiment

    Phreesia has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Phreesia this week, compared to 5 articles on an average week.
  • Search Interest

    Only 9 people have searched for PHR on MarketBeat in the last 30 days. This is a decrease of -47% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Phreesia insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $461,983.00 in company stock.

  • Percentage Held by Insiders

    5.50% of the stock of Phreesia is held by insiders.

  • Percentage Held by Institutions

    92.10% of the stock of Phreesia is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Phreesia's insider trading history.
Receive PHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phreesia and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PHR Stock News Headlines

Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
Phreesia (NYSE:PHR) Insider Sells $12,314.56 in Stock
See More Headlines

PHR Stock Analysis - Frequently Asked Questions

Phreesia's stock was trading at $16.91 at the start of the year. Since then, PHR stock has decreased by 41.9% and is now trading at $9.8190.

Phreesia, Inc. (NYSE:PHR) released its earnings results on Monday, March, 30th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.07 by $0.04. The business's quarterly revenue was up 15.9% on a year-over-year basis.
Read the conference call transcript
.

Phreesia (PHR) raised $149 million in an initial public offering (IPO) on Thursday, July 18th 2019. The company issued 9,288,194 shares at $15.00-$17.00 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray served as the underwriters for the IPO.

Phreesia's top institutional shareholders include OP Asset Management Ltd (1.27%), Dimensional Fund Advisors LP (0.80%), SG Americas Securities LLC (0.75%) and Bank of New York Mellon Corp (0.30%). Insiders that own company stock include Chaim Indig, Evan Roberts, David Linetsky, Amy Beth Vanduyn, Allison C Hoffman, Balaji Gandhi, Michael Weintraub, Michael J Davidoff, Mark Douglas Smith, Janet Gunzburg, Yvonne Hui, Lisa Egbuonu-Davis and Gillian Munson.
View institutional ownership trends
.

Shares of PHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Phreesia investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), CrowdStrike (CRWD), Arista Networks (ANET) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
3/30/2026
Today
5/07/2026
Next Earnings (Confirmed)
5/27/2026
Fiscal Year End
1/31/2027

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Business Services
Current Symbol
NYSE:PHR
CIK
1412408
Employees
1,789
Year Founded
2005

Price Target and Rating

High Price Target
$34.00
Low Price Target
$10.00
Potential Upside/Downside
+112.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.58
Research Coverage
19 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.03
Trailing P/E Ratio
59.56
Forward P/E Ratio
35.07
P/E Growth
N/A
Net Income
$2.31 million
Net Margins
0.48%
Pretax Margin
-1.86%
Return on Equity
3.23%
Return on Assets
2.11%

Debt

Debt-to-Equity Ratio
0.41
Current Ratio
1.53
Quick Ratio
1.53

Sales & Book Value

Annual Sales
$480.59 million
Price / Sales
1.24
Cash Flow
$0.77 per share
Price / Cash Flow
12.77
Book Value
$5.59 per share
Price / Book
1.76

Miscellaneous

Outstanding Shares
60,760,000
Free Float
57,421,000
Market Cap
$596.60 million
Optionable
Optionable
Beta
0.89

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NYSE:PHR) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners